Online Reporter
Ivan Zhakata
Zimpapers Correspondent
The Ministry of Health and Child Care has placed health authorities nationwide on high alert following a regional recall of a Nestlé infant formula due to concerns linked to a specific batch circulating in Southern Africa.
In a letter dated January 9, 2026, addressed to all Provincial Medical Directors and City Health Directors, Permanent Secretary Dr Aspect Maunganidze said Nestlé had announced a recall of NAN Special Pro HA 0–12 (800g) in selected countries, with one batch identified as affected within the East and Southern Africa region.
“Nestlé has announced a product recall of NAN Special Pro HA 0–12 800g in certain countries,” he said.
“Based on the available traceability systems, the only product affected in the East and Southern Africa region is one batch of speciality infant formula, currently manufactured in Germany.”
Dr Maunganidze said the affected batch was distributed to South Africa, Eswatini and Namibia, adding that there is no official confirmation that it entered the Zimbabwean market.
However, authorities have been instructed to remain vigilant due to the possibility of cross-border movement of goods.
The recalled product has been identified as Batch Number 51660742F3, manufactured on June 15, 2025, with a best-before date of December 15, 2026, and an 18-month shelf life.
Dr Maunganidze directed health officials, including officers stationed at ports of entry, to intensify surveillance and take immediate action if the product is detected.
“You are advised to ensure that your officers on the ground and ports of entry are on the look-out for the named products, take them off the shelves, and record the quantities and descriptions of the affected products before they are returned to the manufacturer,” he said.
Dr Maunganidze said the precautionary measures are aimed at safeguarding infant health and preventing the affected product from reaching consumers in Zimbabwe.
Health inspectors have been instructed to monitor pharmacies, retail outlets and health facilities, as well as to report any findings through established channels.
Dr Maunganidze said the Ministry of Health and Child Care will continue to engage relevant stakeholders as it monitors developments surrounding the recall.
